AdvanDx Secures $2,166,769 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8409c821-8ba3-4ac7-b7eb-4bcdf7a4af1e&Preview=1 - Date
10/29/2012 - Company Name
AdvanDx - Mailing Address
400 TradeCenter Woburn, MA 01801 - Company Description
AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations. - Website
http://www.advandx.com - Transaction Type
Venture Equity - Transaction Amount
$2,166,769 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
